UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

The surveillance and diagnosis of hepatocellular carcinoma

Danta, M; Barnes, E; Dusheiko, G; (2005) The surveillance and diagnosis of hepatocellular carcinoma. EUR J GASTROEN HEPAT , 17 (5) 491 - 496.

Full text not available from this repository.

Abstract

The increasing incidence of hepatocellular carcinoma (HCC) is becoming a considerable problem in Europe. While no national surveillance programme exists, there is increasing evidence that surveillance programmes are efficacious and may be cost-effective. The prognosis of large, symptomatic HCC is poor and only palliative treatment is available. In contrast small tumours are now amenable to several modes of treatment including liver transplantation, surgical resection and loco-regional ablation with acceptable 5 year survival rates. Therefore, the identification of small lesions through screening should prolong survival. Consequently, the European Association for the Study of the Liver (EASL) has recommended surveillance with ultrasound scans and tests for alpha fetoprotein every 6 months. Screening is now routine clinical practice in many parts of the developed world. (c) 2005 Lippincott Williams & Wilkins.

Type:Article
Title:The surveillance and diagnosis of hepatocellular carcinoma
Keywords:hepatocellular carcinoma, hepatoma, cirrhosis, surveillance, screening, diagnosis, HCV, HBV, CHRONIC LIVER-DISEASE, CHRONIC HEPATITIS-C, SERUM ALPHA-FETOPROTEIN, CIRRHOTIC-PATIENTS, COST-EFFECTIVENESS, BIOCHEMICAL MARKERS, SCREENING-TESTS, VIRUS-INFECTION, CELL DYSPLASIA, UNITED-STATES
UCL classification:UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Medicine (Division of)

Archive Staff Only: edit this record